149 related articles for article (PubMed ID: 32222813)
21. High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Shojaei H; Hong H; Redline RW
Mod Pathol; 2016 Oct; 29(10):1278-88. PubMed ID: 27443515
[TBL] [Abstract][Full Text] [Related]
22. "Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.
Magers MJ; Kao CS; Cole CD; Rice KR; Foster RS; Einhorn LH; Ulbright TM
Am J Surg Pathol; 2014 Oct; 38(10):1396-409. PubMed ID: 24921638
[TBL] [Abstract][Full Text] [Related]
23. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors.
Gallo A; Fankhauser C; Hermanns T; Beyer J; Christiansen A; Moch H; Bode PK
Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848
[TBL] [Abstract][Full Text] [Related]
24. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract][Full Text] [Related]
25. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
26. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Di Filippo G; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674
[TBL] [Abstract][Full Text] [Related]
27. Many postchemotherapy sarcomatous tumors in patients with testicular germ cell tumors are sarcomatoid yolk sac tumors: a study of 33 cases.
Howitt BE; Magers MJ; Rice KR; Cole CD; Ulbright TM
Am J Surg Pathol; 2015 Feb; 39(2):251-9. PubMed ID: 25229769
[TBL] [Abstract][Full Text] [Related]
28. Yolk sac tumor in postmenopausal patients: pure or associated with adenocarcinoma, a rare phenomenon.
Roma AA; Przybycin CG
Int J Gynecol Pathol; 2014 Sep; 33(5):477-82. PubMed ID: 25083963
[TBL] [Abstract][Full Text] [Related]
29. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
Ulbright TM
Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396
[TBL] [Abstract][Full Text] [Related]
30. Yolk sac tumours revisited. A review of their many faces and names.
Nogales FF; Preda O; Nicolae A
Histopathology; 2012 Jun; 60(7):1023-33. PubMed ID: 22008025
[TBL] [Abstract][Full Text] [Related]
31. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
32. Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal.
Fadare O; Shaker N; Alghamdi A; Ganesan R; Hanley KZ; Hoang LN; Hecht JL; Ip PP; Shaker N; Roma AA; Parkash V; Abubakr H
Mod Pathol; 2019 Dec; 32(12):1847-1860. PubMed ID: 31375771
[TBL] [Abstract][Full Text] [Related]
33. The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
Teilum G; Albrechtsen R; Norgaard-Pedersen B
Acta Pathol Microbiol Scand A; 1975 Jan; 83(1):80-6. PubMed ID: 47695
[TBL] [Abstract][Full Text] [Related]
34. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
[TBL] [Abstract][Full Text] [Related]
35. A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
Al-Hussaini M; Al-Othman Y; Hijazi E; McCluggage WG
Int J Gynecol Pathol; 2018 May; 37(3):275-283. PubMed ID: 28582340
[TBL] [Abstract][Full Text] [Related]
36. [Primary testicular yolk sac tumor: clinicopathological study of 8 cases].
Liu FF; Wang JJ; Shen Q; Yu B; Lu ZF; Ma HH; Shi QL
Zhonghua Nan Ke Xue; 2014 May; 20(5):435-8. PubMed ID: 24908735
[TBL] [Abstract][Full Text] [Related]
37. A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markers.
Hammer PM; Kolin DL; Charville GW; McCluggage WG; Howitt BE
Histopathology; 2022 Sep; 81(3):342-351. PubMed ID: 35758187
[TBL] [Abstract][Full Text] [Related]
38. Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature.
Young RH; Wong A; Stall JN
Am J Surg Pathol; 2022 Mar; 46(3):309-325. PubMed ID: 34469331
[TBL] [Abstract][Full Text] [Related]
39. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
40. Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation.
Ricci C; Ambrosi F; Grillini A; Massari F; Fiorentino M; Colecchia M; Ulbright TM; Acosta AM
Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]